Clinical Trials in Miami

Showing 3541-3560 of 9,821 trials

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

NCT05546580

Iadademstat is being studied as a treatment for subjects with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+). During the trial, iadademstat will be given in combination with gilteritinib, a drug that is already approved to treat patients with FLT3-mutated R/R AML.

Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory

Oryzon Genomics S.A.50 participantsStarted Nov 2022

Gilbert, Arizona, United States • Tucson, Arizona, United States • Miami, Florida, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

NCT03830866

This is a randomized, multi-center, double-blind, placebo-controlled, global, Phase III study to determine the efficacy and safety of durvalumab + Chemoradiotherapy versus Chemoradiotherapy alone as treatment in Women With Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer

AstraZeneca770 participantsStarted Feb 2019

Phoenix, Arizona, United States • La Jolla, California, United States • Orange, California, United States +114 more locations

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Find Trials by Condition in Miami

Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis

Oral Nutritional Supplementation in Children at Risk of Undernutrition

C-myc Biomarker Study for Diabetic Foot Ulcers

Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

Belimumab Assessment of Safety in SLE

Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)

Metastatic Solid Cancer Clinical Trial

Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy

A Study to Learn About Sickle Cell Disease In Adult Patients

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine